A clinical-stage gene therapy company announced Tuesday it has tapped an experienced in-house attorney to lead its legal team.

Cambridge, Massachusetts-based Voyager Therapeutics appointed Robert Hesslein as its general counsel. He will start in April.

“I am delighted to welcome Bob as our general counsel and latest member of our executive management team,” said Andre Turenne, Voyager's president and CEO. “Bob brings a wealth of legal and executive experience that will be invaluable as we continue to advance our efforts to develop needed therapies for patients suffering from severe neurological disorders.”